ArticleEClinicalMedicine2026

Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.

Trine Alma Knudsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.